Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B [2]

Clinical Infectious Diseases

Volumn 44, Issue 2, 2007, Pages 311-312

  Amato, Valdir Sabbaga ^a,b   Tuon, Felipe Francisco ^a   Campos, Aleia ^a   Bacha, Helio Arthur ^a   Nicodemo, Antonio Carlos ^a   Neto, Vicente Amato ^a   Shikanai Yasuda, Maria Aparecida ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIMONY DERIVATIVE;

CLINICAL FEATURE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; GLOMERULUS FILTRATION RATE; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; LEISHMANIASIS; LETTER; NEPHROTOXICITY; PRIORITY JOURNAL; SIDE EFFECT; TRAVEL; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

AGED; AMPHOTERICIN B; ANTIPROTOZOAL AGENTS; DRUG COMBINATIONS; FEMALE; HUMANS; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS; PILOT PROJECTS;

EID: 33846168440     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/510494     Document Type: Letter

References (8)

1. Singh S, Sivakumar R. Challenges and new discoveries in the treatment of leishmaniasis. J Infect Chemother 2004; 10:307-15.
2. Marsden PD. Mucosal leishmaniasis. Trans R Soc Trop Med Hyg 1986; 80:859-76.
3. Amato VS, Rabello A, Rotondo-Silva A, et al. Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients. Acta Trop 2004; 92:127-32.
4. Nonata R, Sampaio R, Marsden PD. Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome, Trans R Soc Trop Med Hyg 1997; 91:77.
5. Vogelsinger H, Weiler S, Djanani A, et al. Amphotericin B tissue distribution in autopsy material after treatment with liposomal amphotericin B and amphotericin B colloidal dispersion. J Antimicrob Chemother 2006; 57:1153-60.
6. Alving CR. Delivery of liposome-encapsulated drugs to macrophages. Pharmacol Ther 1983; 22:407-24.
7. Aronson NE, Wortmann GW, Johnson SC, et al. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience. Clin Infect Dis 1998; 27:1457-64.
8. Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997; 24: 684-703.